BSX.PRA
Allianz Asset Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-2,501,010
| Closed | -$254M | – | 1728 |
|
2022
Q2 | $254M | Sell |
2,501,010
-316,830
| -11% | -$32.1M | 0.24% | 91 |
|
2022
Q1 | $328M | Buy |
2,817,840
+270,000
| +11% | +$31.4M | 0.24% | 90 |
|
2021
Q4 | $292M | Buy |
+2,547,840
| New | +$292M | 0.2% | 106 |
|
2020
Q4 | – | Sell |
-1,346,025
| Closed | -$151M | – | 1939 |
|
2020
Q3 | $151M | Buy |
1,346,025
+115,025
| +9% | +$12.9M | 0.18% | 128 |
|
2020
Q2 | $129M | Buy |
+1,231,000
| New | +$129M | 0.15% | 140 |
|